All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

72

Reset

72 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • AmlitelimabSAR445229Phase 39 trials

    Sanofi · Dermatitis Atopic, Coeliac Disease, Celiac Disease

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • HSK44459Phase 39 trials

    Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • SHR-1819Phase 38 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Seasonal Allergic Rhinitis, Moderate to Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis

  • TLL-018Phase 38 trials

    Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria

  • barzolvolimabCDX-0159Phase 37 trials

    Celldex Therapeutics · Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria

  • MG-K10Humanized Monoclonal AntibodyPhase 36 trials

    Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis

  • SHR-1905Phase 36 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • VC005Phase 35 trials

    Jiangsu vcare pharmaceutical technology co., LTD · Non-segmental Vitiligo, Non-Segmental Vitiligo, Atopic Dermatitis

  • ICP-332Phase 34 trials

    Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis

  • Jaktinib HydrochloridePhase 34 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Atopic Dermatitis, Ankylosing Spondylitis

  • Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)

  • RezpegaldesleukinNKTR-358, REZPEGPhase 34 trials

    Nektar Therapeutics · Moderate-to-Severe Atopic Dermatitis, Moderate to Severe Atopic Dermatitis, Alopecia Areata

  • LNK01001Phase 33 trials

    Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis

  • QY201Phase 33 trials

    E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · Adult Subjects With Non-Segmental Vitiligo, Atopic Dermatitis (AD), Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)

  • RocatinlimabAMG 451Phase 33 trials

    Amgen · Atopic Dermatitis

  • TQH2722Phase 33 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis

  • ADSTEM Inj.Phase 32 trials

    EHL Bio Co., Ltd. · Atopic Dermatitis

  • BFB759Phase 32 trials

    Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • calcineurin inhibitorsPhase 32 trials

    Sanofi · Dermatitis Atopic

  • CMS-D001Phase 32 trials

    Dermavon Holdings Limited · Moderate to Severe Plaque Psoriasis, Moderate to Severe Atopic Dermatitis

  • MH004Phase 32 trials

    Minghui Pharmaceutical (Hangzhou) Ltd · Vitiligo, Atopic Dermatitis (AD)

  • SoquelitinibCPI-818Phase 32 trials

    Corvus Pharmaceuticals, Inc. · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

  • StapokibatrtPhase 32 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis

  • VC005 groupPhase 32 trials

    Jiangsu vcare pharmaceutical technology co., LTD · Atopic Dermatitis, Moderate to Severe Atopic Dermatitis

  • GS101Phase 31 trial

    Jiangsu Genscend Biopharmaceutical Co., Ltd · Atopic Dermatitis (AD)

  • IBI3027Phase 31 trial

    Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis

  • LW402Phase 31 trial

    Shanghai Longwood Biopharmaceuticals Co., Ltd. · Moderate to Severe Atopic Dermatitis

  • PG-011GelPG-011Gel 3%Phase 31 trial

    Prime Gene Therapeutics Co., Ltd. · Atopic Dermatitis

  • QL2108Phase 31 trial

    Qilu Pharmaceutical Co., Ltd. · Atopic Dermatitis

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • ENV-294Phase 23 trials

    Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma

  • GalvokimigUCB9741Phase 23 trials

    UCB · Chronic Obstructive Pulmonary Disease With Chronic Bronchitis, Atopic Dermatitis, Non-cystic Fibrosis Bronchiectasis

  • GIA632Phase 23 trials

    Novartis · Atopic Dermatitis, Non-segmental Vitiligo, Cutaneous Lichen Planus

  • IMG-007Phase 23 trials

    Inmagene LLC · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema

  • KT-621Phase 23 trials

    Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)

  • LT-002-158Phase 23 trials

    Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)

  • QLS12010Phase 23 trials

    Qilu Pharmaceutical Co., Ltd. · Adults With Moderate-to-severe Hidradenitis Suppurativa, Moderate-to-severe Atopic Dermatitis, Rheumatoid Arthritis (RA)

  • RSS0393Phase 23 trials

    Jiangsu HengRui Medicine Co., Ltd. · Psoriatic Subjects, Plaque Psoriasis in Children, Plaque Psoriasis in Adolescents

  • AB-101zabalafinPhase 22 trials

    Alphyn Biologics · Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis

  • ADX-914bempikibartPhase 22 trials

    Q32 Bio Inc. · Atopic Dermatitis, Alopecia Areata

  • AK120JAK inhibitor users need to double the initial dosePhase 22 trials

    Akeso · Atopic Dermatitis

  • APG777Phase 22 trials

    Apogee Therapeutics, Inc. · Atopic Dermatitis

  • CamoteskimabAPL-9109Phase 22 trials

    Apollo Therapeutics Ltd · Atopic Dermatitis, Atopic, Dermatitis

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.